A major real-world study published in early 2026 led by researchers at Johns Hopkins Bloomberg School of Public Health and analysing electronic health records from approximately 175,000 people with T1D in the US found that those taking GLP-1 drugs had a roughly 15% lower five-year risk of major cardiovascular events and a 19% lower risk of end-stage kidney disease, without any increase in hospitalisation for DKA or severe hypoglycemia
Some start with more frequent visits and then shift to monthly maintenance
Frequently Asked Questions Why do I feel cold whilst taking retatrutide
Who should avoid using oral Semaglutide
In obesity management, GLP-1RAs in general, and semaglutide in particular, have been shown to induce significant and sustained weight loss in clinical trials (4)
When taking semaglutide or any other GLP-1 medications for weight loss, maintain your lean muscle mass by following these tips: Adequate protein intake A high-protein diet is the most effective and safest way to preserve muscle mass
